1500006I duke university; phase 1 clinical trial units protocol development, implementation and research laboratory analysis task area B phase 1 therapeutic trial for malaria; to 16-0088.B1.0064--17…
Ended Awarded Last action
- Contract number
- HHSN27200005
- Awardee
-
Duke University UEI TP7EK8DZV6N5
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,105,503
Award facts
- Opportunity
-
- NIAIDDMIDNIHAI2013178 Solicitation number
- Contract value 100% obligated
- $1,105,503.18 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541711 Research and Development in Biotechnology
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
- Pricing
- Cost No Fee
- Place of performance
- Durham, NC 27705, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$1,022,885 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $283,088 | |
| Exercise an Option | $1,805,043 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $40,257 |
About this award
This federal contract award is for a Phase 1 clinical trial protocol development, implementation, and research laboratory analysis task for a therapeutic against malaria. The contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Duke University for $40,257. This task is part of the Therapeutics Against Infectious Diseases Phase 1 contract vehicle, which is a larger program supporting the development of therapeutics against infectious diseases. The contract has no set-aside designation and Duke University is the prime contractor. The award has a ceiling value of $1,105,503.18 and an ultimate completion date of September 7, 2022.
Description
1500006I duke university; phase 1 clinical trial units protocol development, implementation and research laboratory analysis task area B phase 1 therapeutic trial for malaria; to 16-0088.B1.0064--17 base; IID can 8470036; $40,257
Quick answers
Who was awarded contract HHSN27200005?
HHSN27200005 was awarded to Duke University by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on March 15, 2017.
How much is contract HHSN27200005 worth?
The government has obligated $1,105,503 on HHSN27200005.
Is contract HHSN27200005 an order under another contract?
Yes. HHSN27200005 is a delivery order under HHSN272201500006I, an indefinite delivery contract, on Therapeutics Against Infectious Diseases Phase 1.
Was contract HHSN27200005 competed?
The extent of competition for HHSN27200005 was full and open competition. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award